Pioneering Experts To Present At IBC's Drug Discovery & Development Of Innovative Therapeutics JAPAN Conference
Westborough, MA - IBC Life Sciences' International Drug Discovery & Development of Innovative Therapeutics JAPAN conference, to take place May 7-9, 2008 at Keio Plaza Hotel in Tokyo, Japan, will feature over 50 international speakers representing 11 countries. The following five keynote and featured presenters have been confirmed to participate. Three keynote presentations will discuss a variety of topics, including the power of innovation, advances in stem cell biology and translational research. Presenters include:
- Kiyoshi Kurokawa, M.D. Ph.D., Chairman, Health Policy Institute, Japan
- Ken-ichi Arai, M.D., Ph.D., Professor Emeritus, University of Tokyo, Founding President, Asia-Pacific IMBN and President & CEO, SBI Biotech Co., Ltd./Gingko Biomedical Research Institute, Japan
- Shinya Yamanaka, M.D., Ph.D., Professor, Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Japan
Featured presentations will examine successful R&D and partnering strategies being used by pharmaceutical and biotechnology companies to build their drug pipelines and move quickly to clinical POC. Presenters include:
- Greg Wiederrecht, Ph.D., Vice President & Head, External Scientific Affairs, Worldwide Licensing and External Research, Merck & Co., Inc., USA
- Jason Rhodes, Vice President, Business Development, Alnylam Pharmaceuticals, USA
"The keynote and featured speaker line up for Drug Discovery & Development of Innovative Therapeutics JAPAN has never been more impressive," said Michael P. Keenan, Project Manager and Producer, IBC Life Sciences. "This year's entire program has been specifically designed to offer both scientific strategies and plenty of one-on-one networking opportunities to find partners and collaborators from around the globe."
SOURCE: IBC Life Sciences